Literature DB >> 632288

The effect of "cap" analogs on reovirus mRNA binding to wheat germ ribosomes. Evidence for enhancement of ribosomal binding via a preferred cap conformation.

B L Adams, M Morgan, S Muthukrishnan, S M Hecht, A J Shatkin.   

Abstract

A variety of compounds related to the 5'-terminal "cap" (m7GpppN) of eukaryotic mRNA's were chemically synthesized and tested as inhibitors of reovirus mRNA binding to wheat germ ribosomes. Under our conditions of mRNA binding to ribosomes, 7-methyl-, 7-ethyl-, and 7-benzyl-GDP, but not GDP, decreased stable initiation complex formation by 70 to 80% at a concentration of 0.1 mM indicating that 7-substitution, but not a specific substituent, was required for the effect. Elimination of the positive charge on the imidazole of the 7-substituted compounds by treatment with alkali destroyed their inhibitory activity. Similarly, reduction to 8-hydro-m7GDP reversibly decreased the activity of m7GDP. The results were consistent with the hypothesis that the positive charge resulting from 7-alkylation provides an active cap conformer for binding via interaction of phosphate oxygens with the positively charged imidazole moiety. In accord with this suggestion, 7-carboxymethyl GDP and 7,8-dimethyl GDP were found to be less inhibitory than m7GDP. A 2-amino group was also important since m7IDP was less effective than m7GDP and 0.1 mM m7XDP did not inhibit ribosome binding. Other poor inhibitors were 6-Cl-m7GDP and 1,7-dimethyl GDP but N2,7-dimethyl GDP, 2'-deoxy-m7GDP, and m7GppI had essentially the same activity as m7GDP.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 632288

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  Emerging therapeutics targeting mRNA translation.

Authors:  Abba Malina; John R Mills; Jerry Pelletier
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-04-01       Impact factor: 10.005

2.  Synthesis of N²-modified 7-methylguanosine 5'-monophosphates as nematode translation inhibitors.

Authors:  Karolina Piecyk; Richard E Davis; Marzena Jankowska-Anyszka
Journal:  Bioorg Med Chem       Date:  2012-06-10       Impact factor: 3.641

3.  Ribavirin is not a functional mimic of the 7-methyl guanosine mRNA cap.

Authors:  Yifei Yan; Yuri Svitkin; Joseph M Lee; Martin Bisaillon; Jerry Pelletier
Journal:  RNA       Date:  2005-08       Impact factor: 4.942

4.  Isolation and characterization of Dcp1p, the yeast mRNA decapping enzyme.

Authors:  T E LaGrandeur; R Parker
Journal:  EMBO J       Date:  1998-03-02       Impact factor: 11.598

5.  Eukaryotic mRNA cap binding protein: purification by affinity chromatography on sepharose-coupled m7GDP.

Authors:  N Sonenberg; K M Rupprecht; S M Hecht; A J Shatkin
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

Review 6.  5'-terminal cap structure in eucaryotic messenger ribonucleic acids.

Authors:  A K Banerjee
Journal:  Microbiol Rev       Date:  1980-06

7.  Identification of the cap binding domain of human recombinant eukaryotic protein synthesis initiation factor 4E using a photoaffinity analogue.

Authors:  D E Friedland; M T Shoemaker; Y Xie; Y Wang; C H Hagedorn; D J Goss
Journal:  Protein Sci       Date:  1997-01       Impact factor: 6.725

8.  Specific inhibition of capped mRNA translation in vitro by m7G5'pppp5'G and m7G5'pppp5'm7G.

Authors:  N L Sasavage; K Friderici; F M Rottman
Journal:  Nucleic Acids Res       Date:  1979-08-10       Impact factor: 16.971

9.  Beta-globin mRNAs capped with m7G, m2.7(2)G or m2.2.7(3)G differ in intrinsic translation efficiency.

Authors:  E Darzynkiewicz; J Stepinski; I Ekiel; Y Jin; D Haber; T Sijuwade; S M Tahara
Journal:  Nucleic Acids Res       Date:  1988-09-26       Impact factor: 16.971

10.  Novel "anti-reverse" cap analogs with superior translational properties.

Authors:  Jacek Jemielity; Tolvert Fowler; Joanna Zuberek; Janusz Stepinski; Magdalena Lewdorowicz; Anna Niedzwiecka; Ryszard Stolarski; Edward Darzynkiewicz; Robert E Rhoads
Journal:  RNA       Date:  2003-09       Impact factor: 4.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.